Biotechnology continues to be a driving force in modern science, with red biotechnology standing out for its transformative role in medical research and patient care. As diseases evolve, healthcare demands increase, and innovation accelerates, there is a growing need for global platforms where ideas, research, products, and people can converge.
United Kingdom, 16-sept-2025: Hundreds of patients with a fast-growing form of lung cancer will soon gain access to a new treatment, after the National Institute for Health and Care Excellence (NICE) approved the use of durvalumab, also known as Imfinzi, on the NHS. The immunotherapy, developed by AstraZeneca, has been
London, UK: The London Biotechnology Show, Europe’s premier platform dedicated to red biotechnology, is set to return for its third annual edition at Excel London on 9 –10 June 2026. Recognised as a flagship gathering for the global biotech community, the show serves as a catalyst for advancing red
London, June 24: Last week, the London Biotechnology Show 2025 wrapped up a dynamic two-day run at ExCeL London, reaffirming its position as one of the most influential gatherings in the global life sciences calendar. Drawing a high-calibre audience of industry leaders, researchers, investors, policymakers, and entrepreneurs from around the
London, June 19: Day 1 at the London Biotechnology Show opened to a fantastic start, filled with thought-provoking discussions about crucial topics, groundbreaking innovations on display, a highly engaged community of industry professionals, investors, startups, and policymakers from around the world and satisfactory feedback from the attendees. The day began